Gennex Laboratories Share Price
14 Aug, 2026 4:01 PM (IST)
Gennex Laboratories Performance
- Today's Low
- ₹10
- Today's High
- ₹11
- 52 Week Low
- ₹7
- 52 Week High
- ₹17
- Open Price₹10
- Previous Close₹10
- Volume4,595,179
- 50 DMA₹9.60
- 100 DMA₹10.20
- 200 DMA₹11.00
Gennex Laboratories Chart
Investment Returns
- Over 1 Month + 16.38%
- Over 3 Month + 13.45%
- Over 6 Month -11.91%
- Over 1 Year -10.89%
Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!
Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.1
- PEG Ratio
- 0.3
- Market Cap Cr
- 262
- P/B Ratio
- 1.2
- Average True Range
- 0.5
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 72.9
- MFI
- 76.39
Latest Stock News Updates
In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended June 30, 2026. 2. Limited Review Reports from Statutory auditors on Unaudited Standalone and Consolidated Financial Statement for Quarter ended June 30, 2026. 3. Other items We hereby submit that the meeting had commenced at 4.00 PM and concluded at 4.40 PM.
- BSE India
- 1 day 17 hours ago
In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2026 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2026 (annexed here with); 3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM. This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
- BSE India
- 1 day 17 hours ago
Pursuant to Regulation 47 of SEBI (LODR), Regulations, 2015, please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday, August 14, 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30, 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30, 2026. We request you to take the above information on record and acknowledge receipt of the same.
- BSE India
- 2 weeks 2 days ago
Gennex Laboratories Financials
Gennex Laboratories Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹9.30
- 50 Day
- ₹9.60
- 100 Day
- ₹10.20
- 200 Day
- ₹11.00
Resistance and Support
- R3 12.80
- R2 11.90
- R1 11.40
- S1 9.90
- S2 9.00
- S3 8.50
Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-14 | Quarterly Results | |
| 2026-05-30 | Audited Results | |
| 2026-04-16 | Others | Inter-alia, to consider 1. Decide regarding the conduct of EGM for Regularization of Additional Director Ms. Khushbu Kachhawa as a Director. 2. Appoint Scrutinizer for EGM. 3. Other business matters. |
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results |
About Gennex Laboratories
Gennex Laboratories is engaged in the business of manufacturing of Bulk Drugs and Intermediaries. View More- NSE Symbol
- GENNEX
- BSE Symbol
- 531739
- ISIN
- INE509C01026
Similar Stocks to Gennex Laboratories
Popular Stocks
Gennex Laboratories FAQs
Gennex Laboratories share price is ₹10 As on 16 August, 2026 | 09:56
The Market Cap of Gennex Laboratories is ₹262.4 Cr As on 16 August, 2026 | 09:56
The P/E ratio of Gennex Laboratories is 11.1 As on 16 August, 2026 | 09:56
The PB ratio of Gennex Laboratories is 1.2 As on 16 August, 2026 | 09:56
The 52 week High & Low of Gennex Laboratories is ₹17.2/₹7 respectively As on 16 August, 2026 | 09:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.